Li Auto Breaches Historical Floor; Reversal Hinges On L Series Execution

LI faces near-term headwinds from intensifying domestic competition and only nascent global sales in H2’26, with FY2025/FY2026 expected to be trough years before a potential recovery starting in FY2027. Aggressive discounting is pressuring top and bottom lines, though cash burn remains supported by a rich balance sheet. The refreshed L series, now at higher ASPs, is already showing robust order books and offers a potential H2’26 rebound if capacity ramps further.

Analysis

The market is likely underpricing how long a China auto price war can keep a premium OEM in the penalty box. With cash burn cushioned by balance-sheet strength, this is not a solvency story; it is a duration/multiple story where FY25-FY26 can stay depressed long enough for the stock to screen as a value trap rather than a cyclical recovery.

Second-order, the losers are not just LI’s shareholders but also any premium-leaning Chinese EV peer without vertical integration or brand scale: NIO and XPEV remain more margin-sensitive if discounting persists. BYD is the cleaner winner because it can weaponize cost and manufacturing scale while still protecting share, which usually forces weaker players to fund demand with cheaper inventory and dealer incentives.

The key watch item is whether the refreshed higher-ASP lineup converts orders into shipments fast enough to offset legacy model erosion; if capacity lags, the order book is more signaling than cash flow. Near-term catalysts are monthly delivery prints and any further price cuts; the thesis breaks only if gross margin, ASP, and sequential deliveries all inflect together for multiple months, not on one strong order announcement.

Key Decisions for Investors

• Short LI on rallies over the next 2-6 weeks; this is a multiple-compression trade, not a bankruptcy trade. Cover if sequential gross margin or delivery momentum inflects for 2 straight months.
• Pair trade: long BYD / short LI for 1-3 months. BYD has the best ability to win a prolonged discounting cycle; LI needs clean execution just to defend share.
• Avoid chasing LI strength until capacity ramp data confirms the refreshed L-series orders are converting into deliveries. Treat any order-book headlines as unconfirmed until reported revenue and margin follow-through.
• Set an alert on LI for two consecutive months of improving auto gross margin and delivery growth above expectations; that would falsify the trough-year thesis and justify covering shorts.
• For higher-risk exposure, consider LI Jan-2027 calls only after evidence of margin stabilization. Before that, the implied recovery path is too dependent on execution and timing.